Lozada, Keeran Aziel S.
HRN: 24-14-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CIPROFLOXACIN 500MG (TAB)
12/19/2023
12/26/2023
PER OREM
30mg/pptab
Bid
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes